Skip to main content
. Author manuscript; available in PMC: 2023 Jul 26.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2021 Oct 26;31(1):106143. doi: 10.1016/j.jstrokecerebrovasdis.2021.106143

Fig. 2.

Fig. 2.

Primary prophylactic ASM administration did not significantly influence disability (mRS ≥ 3) at 90 days among total ICH patients (A; n = 1208) or patients with primary lobar hemorrhage (B; n = 436).